Propel Bio Management’s Plains GP Holdings PAGP Stock Holding History

Propel Bio Management’s Portfolio PAGP Stock Details PAGP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30.9M	Hold	1,272,360	–	–	16.16%	1
2026 Q1	$30.2M	Hold	1,272,360	–	–	19.02%	1
2025 Q4	$24.4M	Hold	1,272,360	–	–	20.79%	1
2025 Q3	$23.2M	Hold	1,272,360	–	–	23.23%	1
2025 Q2	$24.7M	Hold	1,272,360	–	–	30.01%	1
2025 Q1	$27.2M	Hold	1,272,360	–	–	31.57%	1
2024 Q4	$23.4M	Hold	1,272,360	–	–	23.23%	1
2024 Q3	$23.5M	Sell	1,272,360 -100,000	-7%	-$1.9M	13.65%	2
2024 Q2	$25.8M	Buy	+1,372,360	New	+$25.2M	16.75%	2
2024 Q1	–	Sell	-1,372,360	Closed	-$21.9M	–	34
2023 Q4	$21.9M	Buy	+1,372,360	New	+$21.7M	18.15%	1

Other funds holding PAGP

TCA

Tortoise Capital Advisors Overland Park, Kansas $9.84B AUM 26.47% 1-Year Est. Return

EIP

Energy Income Partners Westport, Connecticut $6.36B AUM 17.8% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

CCM

Chickasaw Capital Management Memphis, Tennessee $2.78B AUM 20.87% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Propel Bio Management's PAGP Position: Q2 2026 in Review

Propel Bio Management held its Plains GP Holdings (PAGP) position steady in Q2 2026 at 1,272,360 shares worth $30.9M. The position accounts for 16.16% of the portfolio, ranked #1.

Propel Bio Management first reported a position in PAGP in Q4 2023 and has held it in 10 quarters since. 342 funds tracked by Wall St. Rank hold PAGP as of Q2 2026.

Propel Bio Management held 1,272,360 shares of Plains GP Holdings worth $30.9M as of Q2 2026.
Propel Bio Management left its Plains GP Holdings share count unchanged in Q2 2026.
Plains GP Holdings made up 16.16% of Propel Bio Management's portfolio in Q2 2026, its #1 holding.
Propel Bio Management first reported a position in Plains GP Holdings in Q4 2023 and has held it in 10 quarters since.
342 funds tracked by Wall St. Rank held Plains GP Holdings as of Q2 2026.

Based on Propel Bio Management's 13F filing for Q2 2026, filed 13 Aug 2026.